AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 9 - (NewsRx.com & NewsRx.net) -- An economic evaluation of options for measles vaccination strategies in a hypothetical Western European country has been published recently.
"In this study, an analysis was made of economic costs and medical effects (by cost-effectiveness and cost-benefit analysis) associated with measles vaccination in a hypothetical Western European country," investigators in Belgium and England report.
"We analyzed 10 vaccination options in terms of past and future vaccination coverage," said Philippe Beutels at the University of Antwerp in Belgium and N. J. Gay at the Public Health Laboratory Service in UK. "We show that several of the proposed strategies for improving measles vaccination coverage are preferable to maintaining the existing policies, regardless of past coverage and the viewpoint of the analysis. For society, very high coverage (95%) two-dose vaccination is most optimal, irrespective of past vaccination coverage."
"The addition of a one-time campaign (to reduce susceptibility in (pre-)adolescent age groups) to such a high coverage two-dose vaccination program is cost-saving to the health-care payer and to society when coverage in ...
Source: HighBeam Research, Economic evaluation of measles vaccination options reviewed.